These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10335769)
1. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Glueck CJ; Lang JE; Tracy T; Sieve-Smith L; Wang P Am J Cardiol; 1999 May; 83(10):1490-4, A8. PubMed ID: 10335769 [TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530 [TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study. Runchey SS; Folsom AR; Tsai MY; Cushman M; McGovern PD Br J Haematol; 2002 Dec; 119(4):1005-10. PubMed ID: 12472581 [TBL] [Abstract][Full Text] [Related]
4. Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease. Puisieux F; de Groote P; Masy E; Di Pompeo C; Millaire A; Bouillanne O; Jude B; Dewailly P; Ducloux G Am J Med; 2000 Dec; 109(8):635-41. PubMed ID: 11099683 [TBL] [Abstract][Full Text] [Related]
5. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis. Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794 [TBL] [Abstract][Full Text] [Related]
6. Vascular dementia and anticardiolipin antibodies. de Godoy JM; de Godoy MR; Cipulo JP; Tognola VA Med Sci Monit; 2005 Sep; 11(9):CR430-3. PubMed ID: 16127362 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical and Hematologic Factors Associated with Stenosis and Aneurysm Development in Patients with Atherosclerotic Arterial Disease. Park SJ; Kim H; Park JK Ann Vasc Surg; 2019 Oct; 60():165-170. PubMed ID: 31195106 [TBL] [Abstract][Full Text] [Related]
8. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations. Wolf P; Gretler J; Aglas F; Auer-Grumbach P; Rainer F Br J Dermatol; 1994 Jul; 131(1):48-51. PubMed ID: 8043421 [TBL] [Abstract][Full Text] [Related]
9. Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus. Oger E; Lernyer C; Dueymes M; Le Moigne E; Bressolette L; Escoffre M; Youinou P; Mottier D Lupus; 1997; 6(5):455-61. PubMed ID: 9229365 [TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies in leprosy. Thawani G; Bhatia VN; Mukherjee A Indian J Lepr; 1994; 66(3):307-14. PubMed ID: 7861045 [TBL] [Abstract][Full Text] [Related]
11. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633 [TBL] [Abstract][Full Text] [Related]
12. [Anticardiolipin antibodies in leg ulcers]. Skare TL; Ribas CA; Malafaia O; Ribas Filho JM; Nassif PA; Nascimento MM; Fonseca VR Rev Col Bras Cir; 2009 Apr; 36(2):152-6. PubMed ID: 20076888 [TBL] [Abstract][Full Text] [Related]